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Long-term results of postoperative radiotherapy in adult patients
with incompletely excised infratentorial low grade astrocytoma
El˝bieta Pluta, Bogdan Gliƒski, Teresa Szpytma, Jadwiga Nowak-Sadzikowska
I n t r o d u c t i o n. Infratentorial low grade astrocytoma (ILGA) occurs rarely in adult patients and accounts for about 3% of
all intracranial tumors. The basic method of treatment for ILGA is surgery. Complete resection results in high local control
rate and the role of postoperative irradiation in management of partially resected tumors is not clearly determined.
The a i m  of this study was to evaluate the efficacy of postoperative irradiation in adult patients with incompletely excised
ILGA.
M a t e r i a l  a n d  m e t h o d s. Between 1975 and 1995, thirty one adult patients with incompletely excised ILGA received po-
stoperative irradiation with curative intent. All patients were treated with megavoltage gamma rays (60Co). The total dose ran-
ged from 50 to 60 Gy (mean; 54 Gy) and was delivered with daily fraction of 1.8-2 Gy. The treatment volume covered the tu-
mor being area with a margin of 1-2 cm.
R e s u l t s. Tolerance to treatment has been found to be good in 30 patients (97%). The overall 15-year actuarial survival ra-
te was 62% in the entire group. Young patients, up to twenty years of age achieved a 15-year overall actuarial survival rate of
85%, older patients – 46%. This difference was statistically significant (p=0.0205).
C o n c l u s i o n. Conventionally fractionated postoperative radiotherapy with doses of 50 to 60 Gy may improve long term re-
sults of adult patients with ILGA after uncomplete resection. Age is a significant prognostic factor – young patients, up to twen-
ty years of age, show best survival.
Odleg∏e wyniki pooperacyjnej radioterapii chorych doros∏ych
na podnamiotowe gwiaêdziaki mózgu o niskiej z∏oÊliwoÊci histologicznej
W s t ´ p. Podnamiotowe gwiaêdziaki o niskiej z∏oÊliwoÊci histologicznej (PGNZH) stanowià oko∏o 3% wszystkich guzów Êród-
czaszkowych u doros∏ych. Podstawowà metodà leczenia tych nowotworów jest neurochirurgia, która w przypadku radykalne-
go usuni´cia guza pozwala na uzyskanie wysokiego odsetka kontroli miejscowej. Rola uzupe∏niajàcego napromieniania po za-
biegach niedoszcz´tnych nie jest okreÊlona w sposób jednoznaczny.
C e l  p r a c y. Ocena wartoÊci pooperacyjnej radioterapii chorych doros∏ych na PGNZH po nieradykalnych zabiegach chirur-
gicznych.
M a t e r i a ∏  i m e t o d y. W latach 1975-1995 napromieniano pooperacyjnie 31 chorych doros∏ych na PGNHZ po nierady-
kalnych zabiegach chirurgicznych drogà kraniotomii. Radioterapi´ prowadzono w warunkach telegammaterapii 60Co. Daw-
ka ca∏kowita wynosi∏a od 50 do 60 Gy (Êrednia 54 Gy), frakcjonowana po 1,8-2 Gy dziennie. Teren napromieniany obejmo-
wa∏ pozosta∏oÊç guza z marginesem 1-2cm.
W y n i k i. Dobrà tolerancj´ leczenia wykaza∏o 30 chorych, tj. 97% materia∏u. W ca∏ej omawianej grupie prognozowane
ca∏kowite prze˝ycie 15 letnie wynios∏o 62%.Dla chorych m∏odych w wieku do 20 lat wynios∏o ono 85%, w porównaniu do 46%
w grupie chorych starszych. Ró˝nica w prze˝yciach by∏a statystycznie istotna (p=0,0205).
W n i o s k i. Klasycznie frakcjonowana radioterapia pooperacyjna w dawce 50-60 Gy mo˝e poprawiç prze˝ycie odleg∏e chorych
na PGNZH po nieradykalnych zabiegach chirurgicznych, Wiek chorych w istotny sposób determinuje rokowanie, najd∏u˝sze
prze˝ycia obserwuje si´ u chorych do 20 roku ˝ycia.
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Introduction
Infratentorial low grade astrocytoma(ILGA) occurs rare-
ly in adult patients and accounts for 3% of all intracranial
tumors [1].
The therapeutic management of ILGA is almost exc-
lusively surgical. Total excision is the treatment of choice,
when possible, but approximately 40% of patients under-
go subtotal resection. It may still be followed by prolon-
ged survival and the role of postoperative irradiation in
this group of patients is not clearly determined [1]. The
objective of this study is to evaluate the efficacy of posto-
perative radiotherapy in adult patients with incompletely
excised ILGA.
Material and methods
Between 1975 and 1995, 719 adult patients with primary intracra-
nial tumors received postoperative irradiation with curative in-
tent in the Center of Oncology in Cracow. The tumor was supra-
tentorial in 625 (87%) cases, and infratentorial in 94 (13%).
The distribution of pathological characteristics of 94 infratento-
rial tumors is given in Table I.
Table I. Histology of 94 infratentorial tumors treated
with postoperative irradiation






High grade astrocytoma 3 4
*other 3 4
ILGA- infratentorial low grade astrocytoma
TBVO-tumors of blood vessel origin
* two cases of ependymoma and one case of sarcoma
The present series consists of 31 cases of infratentorial
low grade astrocytomas (ILGA). All patients underwent open
craniotomy: for partial resection in 18 cases, and for subtotal re-
moval in 13 cases. The diagnosis was histologically confirmed, all
surgical specimens were evaluated by the same pathologist accor-
ding to the criteria of the World Health Organisation classifica-
tion [2]. By histological subtype six were fibryllar, twelve proto-
plasmic, and thirteen represented gemistocytic variant. Clinical
characteristics of these 31 patients are presented in Table II.
Radiotherapy was started three to five weeks after surgery
and was given with a 60 Cobalt unit. The total dose ranged from
50 to 60 Gy (mean; 54 Gy) delivered with daily fractions of 1.8-
-2 Gy. We applied the two- field technique (oblique portals with
wedges) in 26 patients and the three-field technique (parallel-
opposed lateral portals with wedges and posterior) in 5 patients.
The treatment volume covered the tumor residual with a margin
of 1-2 cm.
Results
To l e r a n c e  t o  t r e a t m e n t
The treatment was generally well tolerated. All patients
had mild erythema of the scalp. Signs and symptoms of in-
creased intracranial pressure occurred in two cases, and
resolved with steroid administration. One patient had in-
termittent vomiting which caused a three-day break in
radiotherapy.
S u r v i v a l
The length of survival was measured from the day of sur-
gery, survival plots were generated using the Kaplan-Me-
ier method [5]. The survival data was analysed using the
Gehan modification of the Wilcoxon rank-sum analysis
for comparing arbitrarily censored samples [6]. The survi-
val of all 31 patients with ILGA is presented in Fig.1.
and survival according to the age of patients is shown in
Fig. 2.
In the whole group actuarial survival rate at 15-years
was 62%. Actuarial 15-year survival for 12 patients in the
age up to twenty years was 85%, and 46% for patients
over than 20 years of age. The difference in survival was
statistically significant (p=0.0205).
Treatment results according to clinical and thera-
peutic characteristics are presented in Table III.
Median survival time (MST) according to the clinical
and therapeutic characteristics.
Recurrence was observed in 8 patients. Two relapses
occurred within the first 5 years of follow-up, four be-
tween 6 and 8 years and two relapses were observed after
Table II. Clinical characterististics of 31 adult patients
with ILGA treated
with postoperative irradiation in the Center of Oncology in Cracow
between 1975 and 1995











subtotal resection * 11 35
partial** 20 65
Karnofsky's index [3]
70% and more 21 68
60% and less 10 32
Neurological status according to the 
EORTC/MRC scale [4]




50 Gy 15 48
over 50 Gy 16 52
* Subtotal resection – removal of the whole mass of the tumor except
elements infiltrating deep brain structures
** Partial resection – removal of only some parts of tumor
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10 years of observation. All recurrences were located in
the posterior fossa.
Discussion and conclusions
The place of radiation therapy in the treatment of well
differentiated infratentorial astrocytoma in adults continu-
es to be uncertain, in contrast to childhood cerebellar tu-
mors. It is well known that two features distinguish brain
tumors in children from those in adults. The most signifi-
cant is a higher percentage of gliomas in children, due
to the infrequent occurrence of other common tumors
(ependymoma, meningioma), usually found in adults.
The other important feature is that childhood neopla-
sms occur in the posterior fossa in about 65 to 75 per
cent of the cases, whereas in adults tumors occur in the
supratentorial region. Adult patients with ILGA are quite
rarely referred for radiotherapy, and for some phase of
management. Therefore only a few institutions have eno-
ugh cases to permit irradiation effect evaluation and the
observation of the full course of the disease. Scanning
the literature of the last twenty years we have found only
four papers dealing with ILGA in adults [1, 7-9]. All this
data represents a retrospective view and usually discusses
small groups of patients who had been treated during
a long period of time. It also demonstrate that the use of
radiotherapy in the treatment of ILGA after macroscopi-
cally uncomplete resection is controversial.
In the study of Leibel et al. the treatment groups
were examined according to the completeness of surgical
resection. For patients with incomplete resection, treated
by surgery alone, the 5- and 10-year survival rates were
19% and 11% respectively. These rates were increased to
46% and 35% respectively, when radiation therapy was al-
so given [8]. Since there is no reason to believe that those
irradiated constituted a more favourable patient popu-
lation it seems reasonable to conclude that irradiation
significantly delayed death and may have led to perma-
nent control of disease in some patients. In contrast, in Il-
gren's data, of the 43 patients who had survived subtotal
removal of tumors 11 (26%) underwent radiotherapy,
whilst the remaining 32 (74%) received no further tumor
specific treatment. Analysis of the data revealed no si-
gnificant difference between the two groups in survival or
recurrence-free survival rates [1].
To obtain a clearer view on the matter, we have re-
viewed our material from the years 1975 to 1995, and ha-
ve tried to correlate the clinical and therapeutic aspects of
31 adult patients with incompletely resected ILGA who
had received postoperative radiotherapy. The 10-and 15-
-year actuarial survival rates in our series were 78% and
62% respectively. Our results are comparable to those
reported by other authors (Table IV.)
Our results indicate that age is the principal variable
determining the survival times of patients. This finding is
not new and has been noted in other reports. Hayostec
has observed that prognosis is directly related to the age
of patients with ILGA. Young subjects (up to twenty years
of age) achieved the 10-year survival rate of 89%, as com-
pared to 51% for older patients [7]. According to his ob-
Figure 1. Actuarial overall survival of 31 patients with ILGA Figure 2. Actuarial overall survival according to the age of patients
Table III. Median survival time (MST) of 31 adult patients
with ILGA treated
with postoperative irradiation in the Center of Oncology in Cracow




20 and less 11











70 and more 11






more 50 Gy 9
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servations survival rates in the present series were of 85%
and 46% respectively.
The extent of surgery in our study did not correlate
with survival. There was no statistical difference in pro-
gnosis between patients who had undergone subtotal re-
section of the tumor and those who had undergone partial
excision only. The median survival time (MST) for the
former group was 12 years, compared to 8 years for the
latter. It should be noted, however, that all operations
were non-radical, and thus the differentiation between
subtotal and partial removal is subjective and may be
conducted with a high risk of error.
Tumor location had no influence on survival ti-
me. For patients with hemisphere and vermis sites, the
MST was 11 and 9 years respectively. The relevance of
tumor location is unclear, some authors have observed
better outcome in patients in whom tumors were loca-
ted in the vermis, whereas other reported contradictive
observations. One may speculate that complete removal
of tumor tissue is easier to achieve in vermis located tu-
mors [7, 9].
The sex of the patients did not significantly affect
survival, similarly to Leibel's series [8].
We have not proved a prognostic value of Karno-
fsky's Performance Status and Neurological Status (NS)
on the outcome of our patients, contrary to Hayostek's da-
ta in which NS appeared to be one of the most significant
prognostic factors [7].
In our study, the outcome of patients who received
a total dose of irradiation of 50 Gy was no worse than
that of patients treated with higher doses up – to 60 Gy.
Corresponding MST values were 8 and 9 years. This diffe-
rence was not statistically significant. A review of literatu-
re suggests that optimal range of the total dose in radio-
therapy of ILGA seems to lie somewhere between 50
and 60 Gy [1, 7-9].
Concluding, we can say that our experiences con-
firms that combined surgery plus radiotherapy with doses
of 50 to 60 Gy may improve long term results in adult
patients with infratentorial low grade astrocytomas after
uncomplete resection. In this group of patients age is
a significant prognostic factor, young subjects up to twen-
ty years of age benefit of the best survival.
Furthermore, our findings must be viewed with cau-
tion because they are based on retrospective data of a tre-
atment regimen used over the last 20 years. The optimal
use of radiotherapy in the management of ILGA still ne-
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Table IV. Results of postoperative irradiation in adults 
with incompletely removed ILGA
Author No of 10-year
patients survival
Ilgren et al. [1] 13 46%
Hayostek et al. [7] 44 61%
Leibel et al. [8] 11 64%
Liebner et al.[9] 18 50%
Present series 31 62%
